Transaction DateRecipientSharesTypePriceValue
13th March 2020Roni Appel2,401Open or private sale$0.55$1,320.55
12th March 2020Roni Appel200Open or private sale$0.58$116.00
11th March 2020Roni Appel399Open or private sale$0.67$267.33
11th April 2019Andres Gutierrez3,750Grant/award etc.$3.71$13,928.25
11th April 2019Molly Henderson2,500Grant/award etc.$3.68$9,199.75
10th April 2019Roni Appel3,000Open or private purchase$3.80$11,391.00
9th April 2019Molly Henderson2,900Grant/award etc.$3.86$11,193.71
9th April 2019Molly Henderson100Grant/award etc.$3.85$385.00
8th April 2019Kenneth A Berlin1,100Grant/award etc.$3.78$4,152.50
8th April 2019Kenneth A Berlin2,100Grant/award etc.$3.78$7,935.90
Advaxis logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

Ticker: ADXS
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1100397
Employees: 35
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags